Clinical Trial Update: A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Eltrombopag was investigated in a Phase 2 study of thrombocytopenic patients with myelodysplastic syndromes or acute myeloid leukemia. The results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Thrombocytopaenia | Phase 2 | Status: COMPLETED | Results posted: 2016-06-14